Nucleoprotein (265-273)

Nucleoprotein

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-021

Synonyms/Alias:Nucleoprotein (265-273)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C43H77N15O11
M.W/Mr.
980.17
Sequence
ILRGSVAHK
Areas of Interest
Antigen-presenting Cells; Cancer Research
Source#
Influenza A virus
Epitope
265-273
Restricting HLA
HLA-A3
References
C Gschoesser; Vaccine 2002

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Synthesis ServicesPeptide Analysis ServicesPeptide Modification ServicesPeptide Nucleic Acids SynthesisCustom Conjugation ServiceEpitope Mapping ServicescGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers